REQUEST A DEMO
Total
USD $0.00
Search more companies

Farmasi Fmb Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Farmasi Fmb Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Farmasi Fmb Sdn. Bhd. is based in Malaysia. The head office is in Ipoh. The company operates in the Pharmacies and Drug Stores industry. It was incorporated on November 21, 2014. The latest financial highlights indicate a net sales revenue drop of 0.31% in 2021. Its total assets grew by 9.77% over the same period. The net profit margin of Farmasi Fmb Sdn. Bhd. increased by 3.89% in 2021.

Headquarters
No. 55A, Persiaran Kledang Timur 21, Bandar Baru Menglembu
Ipoh; Perak; Postal Code: 31450

Contact Details: Purchase the Farmasi Fmb Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Farmasi Fmb Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Farmasi Fmb Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Farmasi Fmb Sdn. Bhd. report to view the information.
Incorporation Date:
November 21, 2014
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
70%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after Farmasi Fmb Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-0.31%
Total operating revenue
-0.31%
Operating profit (EBIT)
325.02%
EBITDA
264.4%
Net Profit (Loss) for the Period
282.22%
Total assets
9.77%
Total equity
57.45%
Operating Profit Margin (ROS)
5.16%
Net Profit Margin
3.89%
Return on Equity (ROE)
24.96%
Debt to Equity Ratio
-33.86%
Quick Ratio
0.24%
Cash Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?